Summary 19
The Golgi is the cellular hub for glycosylation, controlling accurate processing of complex proteoglycans 20 and glycolipids. Its structure and organisation is dependent on golgins which tether cisternal membranes 21 and incoming transport vesicles. Here we show that knockout of the largest golgin, giantin, leads to 22 substantial changes in gene expression despite only limited effects on Golgi structure. Notably, 22 Golgi-23 resident glycosyltransferases, but not glycan processing enzymes or the ER glycosylation machinery, are 24 differentially expressed following giantin ablation. Most of these glycosyltransferases are highly 25 downregulated following genetic knockout of giantin, including a near-complete loss of expression of 26 GALNT3 in both mammalian cell and zebrafish models. Furthermore, knockout zebrafish exhibit 27 increased bone mass density, hyperostosis, and ectopic calcium deposits recapitulating phenotypes of 28 hyperphosphatemic familial tumoral calcinosis, a disease caused by mutations in GALNT3. Our data 29 reveal a new feature of Golgi homeostasis, the ability to regulate glycosyltransferase expression to 30 generate a functional proteoglycome. 31
Introduction
In the absence of a clearly defined role for giantin at the Golgi, we sought to study its function in an 99 engineered KO cell line. In this system, as well as a zebrafish model, we show for the first time that 100 giantin regulates the expression of Golgi-resident glycosyltransferases. 101
During mitosis, the Golgi must disassemble and reassemble. As we could not detect any gross defects in 148
Golgi structure in giantin KO cells at steady state, we analysed Golgi dynamics by chemically inducing its 149 disassembly. First, we treated cells with nocodazole, which disassembles microtubules and thus causes 150
Golgi ribbons to fragment into polarised mini-stacks (Thyberg and Moskalewski, 1985) . Under these 151 conditions, the dynamics of disassembly and reassembly were found to be equivalent in both cell lines 152 ( Figure 3A) , with fragmentation of the TGN preceding that of the cis-Golgi as reported previously (Yang 153 and Storrie, 1998). Likewise, Golgi disassembly following brefeldin A treatment (which inhibits the Arf-154 guanine nucleotide exchange factor, GBF1) was comparable in WT and KO cells ( Figure S1 ). We also 155 failed to find any defects in cell cycle progression using propidium iodide labelling and flow cytometry 156 (data not shown). 157
During these Golgi disruption experiments, we noticed a difference in GM130 labelling of WT and KO 158 cells. Following nocodazole treatment, giantin reportedly persists on the original fragmenting 159 membranes (the 'old Golgi') rather than cycling through the ER onto immature peripheral mini-stacks 160 (Fourriere et al., 2016; Nizak et al., 2003) . This is apparent here in WT cells, which show an enrichment 161 of giantin on larger, juxtanuclear structures over more peripheral elements ( Figure 3A) . In KO cells, 162 however, these larger Golgi elements appear to be enriched with GM130. This enrichment is not due to 163 upregulation of GM130 expression as protein levels are equivalent in WT and KO cells ( Figure 3B-C) , 164 suggesting instead that GM130 has either redistributed between Golgi membranes, perhaps to 165 compensate for giantin, or is labelling larger structures not present in WT cells. To distinguish between 166 these possibilities, we examined cells treated with nocodazole for 90 minutes by EM. As expected larger,Surprisingly, EM of nocodazole-treated KO cells showed Golgi elements that had apparently circularized 172 ( Figure 3D , insets). These were absent in WT and untreated KO cells, except for one case of the latter. To 173 quantify curvature of fragmented Golgi elements we calculated the angle between two lines drawn from 174 each Golgi rim to the centre of the stack; circularised Golgi structures were assigned an angle of 0 o and 175 linear stacks 180
o . This analysis showed a significant overall trend towards horseshoe-shaped and 176 circular stacks in the KO cells compared to the WT ( Figure 3G ). Giantin-deficient Golgi stacks therefore 177 exhibit structural abnormalities with low frequency (5% of structures/at least one present in 14% of 178 cells) once fragmented. 179
Glycosylation enzyme expression patterns are altered in giantin KO cells 180
Giantin is a highly-conserved gene essential for viability in rodents (Katayama et al. Tables S1 & S2) . Gene ontology analysis showed that 188 major classes of genes that were differentially expressed encoded highly glycosylated proteins, 189 extracellular matrix components, and adhesion proteins. Of note, twenty-four glycosyltransferases were 190 differentially expressed between the two cell lines. These include a pseudogene (DPY19L2P2), an ER-191 resident glycosyltransferase (UGT8) and twenty-two type II Golgi-resident transmembrane enzymes 192 (Table 1) . Some of these were among the most highly downregulated genes overall. Notably, other localized core glycosyltransferases, glycan processing and modifying enzymes, and the cytosolic 194 glycosylation machinery were unchanged following KO of giantin. 195 To determine the impact of altered glycosyltransferase expression in the KO cells, we looked at global 196 glycosylation patterns using biotinylated lectins to label fixed cells. RCA120 labelling of β-D-galactosyl 197 residues was more bundled in KO cells but otherwise there were no gross changes in glycan abundance 198 or localisation ( Figure S2 ). We also probed cell lysates with lectins by blotting and found only minor 199 changes in glycosylation patterns, namely loss of a 25kDa band when labelling with either ConA or HABP 200 which recognise α-D-mannosyl and α-D-glucosyl residues and hyaluronic acid respectively ( Figure S2) . 201
Glycosylation patterns are therefore largely normal, but with some identifiable changes. 202
GALNT3 expression is dramatically reduced in giantin KO cells 203
To validate the findings of the RNAseq analysis, we first performed immunoblots for two of the more 204 highly downregulated glycosyltransferases, GALNT3 and CHST11 for which reagents were available. This 205 confirmed that expression of these enzymes was reduced at the protein level ( Figure 4A-B) . 206
Immunolabelling of fixed cells further demonstrated a near-complete loss of GALNT3 expression in 207 giantin KO cells ( Figure 4C ). GALNT3 is mutated in the human disease HFTC (Topaz et al., 2004) and so 208 we decided to focus our studies on this gene. 209
We hypothesised that downregulation of GALNT3 could have occurred in response to aberrant 210 trafficking following the loss of giantin function; such mistargeting could result in degradation coupled 211 with a feedback mechanism to downregulate expression. We tested this directly by expressing FLAG-212 tagged GALNT3 in WT and KO cells. Immunofluorescence labelling showed FLAG-GALNT3 is efficiently 213 targeted to the Golgi in both cell lines ( Figure 4D ). GALNT3 localisation is thus independent of giantin
Giantin KO zebrafish phenotypes are consistent with tumoral calcinosis 219
We next sought to explore the role of giantin in regulating glycosyltransferase expression in vivo using 220 two recently characterised golgb1 KO zebrafish lines (Bergen et al., 2017) carrying a point mutation 221
(C>T) in exon 14 leading to generation of a premature stop codon at glutamine-2948 (denoted 222
golgb1
Q2948X/Q2948X ). The second allele was generated by TALEN mutagenesis introducing an 8bp insertion 223 at exon 14. This results in a frameshift at position 3029 leading to a premature stop codon at position 224 3078 (E3027fsX3078-T3028_A3029del, denoted golgb1 3078X/3078X ). Both mutations lead to loss of the 225 transmembrane domain and therefore are expected to be loss-of-function mutations. These fish do not 226 display any gross developmental defects but did have a mild developmental delay and defects in cilia 227 function (Bergen et al., 2017) . 228
First, we performed quantitative PCR of mixed bone and cartilage tissues from both mutant fish lines at 229 60 days post fertilization (dpf). In each case, we observed a significant loss of galnt3 expression ( Figures 5D, S3) . 244
Discussion 246
The data presented here demonstrate for the first time that the Golgi apparatus has the capacity to 247 control its own composition. Specifically, we show that the enzymatic content of the Golgi is altered at 248 the level of transcription in response to loss of giantin function. This process is conserved between 249 mammalian cells and zebrafish models as GALNT3 mRNA is reduced in both giantin KO systems. 250
Furthermore, we demonstrate functional and physiological relevance as giantin KO zebrafish show 251 phenotypes consistent with the human congenital disorder of glycosylation, HFTC. 252
We report that 24 enzymes involved in multiple glycosylation pathways exhibit altered expression 253 following GOLGB1 ablation. This implies that this change is not in response to a deficiency in a single 254 reaction but a global adjustment of Golgi biochemistry. We consider this an adaptive response to giantin 255 loss-of-function and it suggests a plasticity within the system that could have relevance to many 256 Quality control mechanisms, such as may be active here, are well documented in the ER but to our 307 knowledge only one study has looked at this specifically in the Golgi (Oku et al., 2011). This report found 308 ten Golgi-relevant genes were upregulated in response to Golgi stress by virtue of a seven nucleotide 309 cis-acting element within their promoters termed the Golgi apparatus stress response element (GASE) 310 (Oku et al., 2011). We failed to identify these genes in our RNAseq analysis, nor was there any 311 enrichment for promoters containing the GASE motif in our hits. It is therefore unlikely this pathway is 312 active in our KO cells, but perhaps similar mechanisms exist to detect changes in the proteoglycome and 313 adjust transcription accordingly. 314
The lack of major structural changes in the Golgi apparatus in our KO process due to altered glycosyltransferase expression could thus underlie the broad chondrogenesis and 336 osteogenesis phenotypes seen in rodent knockout animals, whilst the diversity seen with regards to 337 phenotypes likely reflects model specific modes of adaptation. The latter will be determined by tissuespecific expression patterns, different developmental pathways, or differing compensatory mechanisms 339 to produce bioequivalent glycans between species. Unlike our zebrafish mutants, HFTC phenotypes have 340 not been reported in rodent giantin KO models however these animals die at birth prior to disease 341 onset, whilst adult KO zebrafish are viable. 342
Overall, our work identifies a previously uncharacterised mechanism through which the Golgi can 343 regulate its own biochemistry to produce a functional proteoglycome. Understanding the ability of cells 344 to adapt and modulate glycosylation pathways through long term changes in gene expression has 345 implications for normal development and disease pathogenesis in diverse contexts including congenital 346 disorders of glycosylation (Jaeken, 2010), the onset and progression of cancer (Pinho and Reis, 2015), 347
and long term health in terms of tissue regeneration and repair. 348
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Materials and Methods 543
All reagents were purchased from Sigma-Aldrich unless stated otherwise.
Method details 545

Cell culture 546
Human telomerase-immortalised retinal pigment epithelial cells (hTERT-RPE1, Takara For RUSH assays, cells were seeded onto 35-mm glass-bottomed dishes (MatTek, Ashland, MA) or 606 coverslips and transfected 24 hr prior to assay; at T0 cells were treated with 40 µM biotin then imaged 607 every 15 seconds as a single plane for up to 1 hr or fixed at specific time points and stained as above. 608
Live widefield microscopy proceeded using an Olympus IX81 microscope with 60x 1.42 numericalmulti-pass emission filters (Semrock). Images were collected using an Orca Flash 2.8 sCMOS controlled 611 using Volocity 5.4.2 (PerkinElmer). Cells were kept at 37 o C for the duration of the imaging. 612
Quantification of Golgi structure from widefield images was performed using ImageJ software. 613
Maximum projection images (GRASP65 channel) were generated from 0.2µm z-stacks and thresholded 614 before applying the analyse particles feature excluding objects <0.5μm 2 or on the edge of the field of 615 view. Golgi cisternal length and curvature measurements taken from micrographs were again made with 616
ImageJ using the segmented line and angle tools. Cisternae number and RUSH experiments were 617 quantified manually and blind. 618 washing 3x with water after each. Once dried, sections were imaged using a FEI Tecnai12. 625
Immunoblotting 626
Cells were lysed in RIPA buffer (50 mM Tris pH7.5, 300 mM NaCl, 2% Triton-X100, 1% deoxycholate, 627 0.1% SDS, 1 mM EDTA) and samples separated by SDS-PAGE followed by transfer to nitrocellulose 628 membranes. Membranes were blocked in 5% milk-TBST or 3% BSA-TBST for antibody and lectin probes 629 respectively. Primary antibodies/lectins diluted in block were incubated with membrane overnight and 630 detected using HRP-conjugated secondary antibodies or streptavidin respectively (Jackson
Quantitative PCR 634
Total RNA was isolated from ventral bone and cartilage of juvenile golgb1 Q2948X and golgb1
3078X
genotyped fish (30 dpf, n=3 per genotype) using RNeasy mini kit (cat# 74104, Qiagen, Manchester, UK). 636
Subsequently, a reverse transcriptase reaction was performed by using SuperscriptIV (cat# 18091050, 637 Thermo Fisher). Zebrafish galnt3 (XM_009300463.2) coding sequence was confirmed by multi-species 638 nucleotide BLAST (NCBI) leading to galnt3 forward 5'-TCCTTCAGAGTGTGGCAGTG and reverse 5'-639 TGATGGTGTTGTGGCCTTTA primers. gapdh as a reference gene was used forward 5'-640 Rev.F). The library preparation involved the initial QC of the RNA using a Tecan plate reader with the 649 Quant-iT™ RNA Assay Kit (Life technologies/Invitrogen Q-33140) and the Quant-iT™ DNA Assay Kit, high 650 sensitivity (Life technologies/Invitrogen Q-33120). Finally, the quality of the RNA was established using 651 the PerkinElmer GX with a high sensitivity chip and High Sensitivity DNA reagents (PerkinElmer 5067-652 4626). RNA quality scores were 8.7 and 9.8 for two of the samples and 10.0 (for the remaining 4 653 samples). 1 ug of RNA was purified to extract mRNA with a poly-A pull down using biotin beads, 654 fragmented and first strand cDNA was synthesised. This process reverse transcribes the cleaved RNA 655 fragments primed with random hexamers into first strand cDNA using reverse transcriptase and randomprimers. The ends of the samples were repaired using the 3' to 5' exonuclease activity to remove the 3' 657 overhangs and the polymerase activity to fill in the 5' overhangs creating blunt ends. A single 'A' 658 nucleotide was added to the 3' ends of the blunt fragments to prevent them from ligating to one 659 another during the adapter ligation reaction. A corresponding single 'T' nucleotide on the 3' end of the 660 adapter provided a complementary overhang for ligating the adapter to the fragment. This strategy 661 ensured a low rate of chimera formation. The ligation of a number indexing adapters to the ends of the 662 DNA fragments prepared them for hybridisation onto a flow cell. The ligated products were subjected to 663 a bead based size selection using Beckman Coulter XP beads (Beckman Coulter A63880) to remove un-664 ligated adapters, as well as any adapters that may have ligated to one another. Prior to hybridisation to 665 the flow cell the samples were amplified by PCR to selectively enrich those DNA fragments that have 666 adapter molecules on both ends and to amplify the amount of DNA in the library. The PCR was 667 performed with a PCR primer cocktail that annealed to the ends of the adapter. The insert size of the 668 libraries was verified by running an aliquot of the DNA library on a PerkinElmer GX using the High 669 Sensitivity DNA chip and reagents (PerkinElmer CLS760672) and the concentration was determined by 670 using the Tecan plate reader. The resulting libraries were then equimolar pooled and Q-PCR was 671 performed on the pool prior to clustering. 672
These six total RNA samples were sequenced over two lanes and aligned against the human genome 673 reference build 38 followed by differential expression analysis between the wildtype and knockout 674 samples. QC was done using FastQC (fastqc version 0.11.2). An in-house contamination-screening 675 pipeline (Kontaminant) was used to check for any obvious contamination in the raw reads. Since the 676 data quality was good, there was no trimming done on the raw reads. Alignment of RNAseq reads to the 677 human genome reference was done using TopHat (tophat version 2.1.0) with "min-anchor-length" 12 678
and "max-multi hits" 20. The log2 of the fold-change was used in further analysis. cells. The first tab shows all data, the second shows those genes that have changed from than 2-fold, the third, those that have changed more than 3-fold. Wash out
Legend to
